orgrctera/uda_fin_qa huggingface dataset:
{"pre_text": ["performance graph the following graph compares the yearly change in the cumulative total stockholder return for our last five full fiscal years , based upon the market price of our common stock , with the cumulative total return on a nasdaq composite index ( u.s .", "companies ) and a peer group , the nasdaq medical equipment-sic code 3840-3849 index , which is comprised of medical equipment companies , for that period .", "the performance graph assumes the investment of $ 100 on march 31 , 2010 in our common stock , the nasdaq composite index ( u.s .", "companies ) and the peer group index , and the reinvestment of any and all dividends. ."], "post_text": ["this graph is not 201csoliciting material 201d under regulation 14a or 14c of the rules promulgated under the securities exchange act of 1934 , is not deemed filed with the securities and exchange commission and is not to be incorporated by reference in any of our filings under the securities act of 1933 , as amended , or the exchange act whether made before or after the date hereof and irrespective of any general incorporation language in any such filing .", "transfer agent american stock transfer & trust company , 59 maiden lane , new york , ny 10038 , is our stock transfer agent. ."], "table": [["", "3/31/2010", "3/31/2011", "3/31/2012", "3/31/2013", "3/31/2014", "3/31/2015"], ["abiomed inc", "100", "140.79", "215.02", "180.91", "252.33", "693.60"], ["nasdaq composite index", "100", "115.98", "128.93", "136.26", "175.11", "204.38"], ["nasdaq medical equipment sic code 3840-3849", "100", "108.31", "115.05", "105.56", "123.18", "118.95"]], "table_ori": [["", "3/31/2010", "3/31/2011", "3/31/2012", "3/31/2013", "3/31/2014", "3/31/2015"], ["ABIOMED, Inc", "100", "140.79", "215.02", "180.91", "252.33", "693.60"], ["Nasdaq Composite Index", "100", "115.98", "128.93", "136.26", "175.11", "204.38"], ["Nasdaq Medical Equipment SIC Code 3840-3849", "100", "108.31", "115.05", "105.56", "123.18", "118.95"]]}

Question: did abiomed outperform the nasdaq composite index over the five year period?
Evidence:
table_1: the abiomed inc of 3/31/2010 is 100 ; the abiomed inc of 3/31/2011 is 140.79 ; the abiomed inc of 3/31/2012 is 215.02 ; the abiomed inc of 3/31/2013 is 180.91 ; the abiomed inc of 3/31/2014 is 252.33 ; the abiomed inc of 3/31/2015 is 693.60 ;
table_2: the nasdaq composite index of 3/31/2010 is 100 ; the nasdaq composite index of 3/31/2011 is 115.98 ; the nasdaq composite index of 3/31/2012 is 128.93 ; the nasdaq composite index of 3/31/2013 is 136.26 ; the nasdaq composite index of 3/31/2014 is 175.11 ; the nasdaq composite index of 3/31/2015 is 204.38 ;
Program: greater(693.60, 204.38)
Answer:
exe_answer: yes
{"pre_text": ["abiomed , inc .", "and subsidiaries notes to consolidated financial statements 2014 ( continued ) note 3 .", "acquisitions ( continued ) including the revenues of third-party licensees , or ( ii ) the company 2019s sale of ( a ) ecp , ( b ) all or substantially all of ecp 2019s assets , or ( c ) certain of ecp 2019s patent rights , the company will pay to syscore the lesser of ( x ) one-half of the profits earned from such sale described in the foregoing item ( ii ) , after accounting for the costs of acquiring and operating ecp , or ( y ) $ 15.0 million ( less any previous milestone payment ) .", "ecp 2019s acquisition of ais gmbh aachen innovative solutions in connection with the company 2019s acquisition of ecp , ecp acquired all of the share capital of ais gmbh aachen innovative solutions ( 201cais 201d ) , a limited liability company incorporated in germany , pursuant to a share purchase agreement dated as of june 30 , 2014 , by and among ecp and ais 2019s four individual shareholders .", "ais , based in aachen , germany , holds certain intellectual property useful to ecp 2019s business , and , prior to being acquired by ecp , had licensed such intellectual property to ecp .", "the purchase price for the acquisition of ais 2019s share capital was approximately $ 2.8 million in cash , which was provided by the company , and the acquisition closed immediately prior to abiomed europe 2019s acquisition of ecp .", "the share purchase agreement contains representations , warranties and closing conditions customary for transactions of its size and nature .", "purchase price allocation the acquisition of ecp and ais was accounted for as a business combination .", "the purchase price for the acquisition has been allocated to the assets acquired and liabilities assumed based on their estimated fair values .", "the acquisition-date fair value of the consideration transferred is as follows : acquisition date fair value ( in thousands ) ."], "post_text": ["."], "table": [["", "total acquisition date fair value ( in thousands )"], ["cash consideration", "$ 15750"], ["contingent consideration", "6000"], ["total consideration transferred", "$ 21750"]], "table_ori": [["", "Total Acquisition Date Fair Value (in thousands)"], ["Cash consideration", "$15,750"], ["Contingent consideration", "6,000"], ["Total consideration transferred", "$21,750"]]}

Question: what portion of total consideration transferred for acquisition of ecp and ais is contingent consideration?
Evidence:
table_1: the cash consideration of total acquisition date fair value ( in thousands ) is $ 15750 ;
table_3: the total consideration transferred of total acquisition date fair value ( in thousands ) is $ 21750 ;
table_2: the contingent consideration of total acquisition date fair value ( in thousands ) is 6000 ;
Program: divide(6000, 21750)
Answer:
str_answer: 27.6%
exe_answer: 0.27586
{"pre_text": ["performance graph the following graph compares the yearly change in the cumulative total stockholder return for our last five full fiscal years , based upon the market price of our common stock , with the cumulative total return on a nasdaq composite index ( u.s .", "companies ) and a peer group , the nasdaq medical equipment-sic code 3840-3849 index , which is comprised of medical equipment companies , for that period .", "the performance graph assumes the investment of $ 100 on march 31 , 2010 in our common stock , the nasdaq composite index ( u.s .", "companies ) and the peer group index , and the reinvestment of any and all dividends. ."], "post_text": ["this graph is not 201csoliciting material 201d under regulation 14a or 14c of the rules promulgated under the securities exchange act of 1934 , is not deemed filed with the securities and exchange commission and is not to be incorporated by reference in any of our filings under the securities act of 1933 , as amended , or the exchange act whether made before or after the date hereof and irrespective of any general incorporation language in any such filing .", "transfer agent american stock transfer & trust company , 59 maiden lane , new york , ny 10038 , is our stock transfer agent. ."], "table": [["", "3/31/2010", "3/31/2011", "3/31/2012", "3/31/2013", "3/31/2014", "3/31/2015"], ["abiomed inc", "100", "140.79", "215.02", "180.91", "252.33", "693.60"], ["nasdaq composite index", "100", "115.98", "128.93", "136.26", "175.11", "204.38"], ["nasdaq medical equipment sic code 3840-3849", "100", "108.31", "115.05", "105.56", "123.18", "118.95"]], "table_ori": [["", "3/31/2010", "3/31/2011", "3/31/2012", "3/31/2013", "3/31/2014", "3/31/2015"], ["ABIOMED, Inc", "100", "140.79", "215.02", "180.91", "252.33", "693.60"], ["Nasdaq Composite Index", "100", "115.98", "128.93", "136.26", "175.11", "204.38"], ["Nasdaq Medical Equipment SIC Code 3840-3849", "100", "108.31", "115.05", "105.56", "123.18", "118.95"]]}

Question: what is the roi of an investment in abiomed inc from march 2010 to march 2013?
Evidence:
table_1: the abiomed inc of 3/31/2010 is 100 ; the abiomed inc of 3/31/2011 is 140.79 ; the abiomed inc of 3/31/2012 is 215.02 ; the abiomed inc of 3/31/2013 is 180.91 ; the abiomed inc of 3/31/2014 is 252.33 ; the abiomed inc of 3/31/2015 is 693.60 ;
Program: subtract(180.91, 100), divide(#0, 100)
Answer:
str_answer: 80.9%
exe_answer: 0.8091
{"pre_text": ["performance graph the following graph compares the yearly change in the cumulative total stockholder return for our last five full fiscal years , based upon the market price of our common stock , with the cumulative total return on a nasdaq composite index ( u.s .", "companies ) and a peer group , the nasdaq medical equipment-sic code 3840-3849 index , which is comprised of medical equipment companies , for that period .", "the performance graph assumes the investment of $ 100 on march 31 , 2010 in our common stock , the nasdaq composite index ( u.s .", "companies ) and the peer group index , and the reinvestment of any and all dividends. ."], "post_text": ["this graph is not 201csoliciting material 201d under regulation 14a or 14c of the rules promulgated under the securities exchange act of 1934 , is not deemed filed with the securities and exchange commission and is not to be incorporated by reference in any of our filings under the securities act of 1933 , as amended , or the exchange act whether made before or after the date hereof and irrespective of any general incorporation language in any such filing .", "transfer agent american stock transfer & trust company , 59 maiden lane , new york , ny 10038 , is our stock transfer agent. ."], "table": [["", "3/31/2010", "3/31/2011", "3/31/2012", "3/31/2013", "3/31/2014", "3/31/2015"], ["abiomed inc", "100", "140.79", "215.02", "180.91", "252.33", "693.60"], ["nasdaq composite index", "100", "115.98", "128.93", "136.26", "175.11", "204.38"], ["nasdaq medical equipment sic code 3840-3849", "100", "108.31", "115.05", "105.56", "123.18", "118.95"]], "table_ori": [["", "3/31/2010", "3/31/2011", "3/31/2012", "3/31/2013", "3/31/2014", "3/31/2015"], ["ABIOMED, Inc", "100", "140.79", "215.02", "180.91", "252.33", "693.60"], ["Nasdaq Composite Index", "100", "115.98", "128.93", "136.26", "175.11", "204.38"], ["Nasdaq Medical Equipment SIC Code 3840-3849", "100", "108.31", "115.05", "105.56", "123.18", "118.95"]]}

Question: what is the roi of an investment in nasdaq composite index from march 2010 to march 2013?
Evidence:
table_2: the nasdaq composite index of 3/31/2010 is 100 ; the nasdaq composite index of 3/31/2011 is 115.98 ; the nasdaq composite index of 3/31/2012 is 128.93 ; the nasdaq composite index of 3/31/2013 is 136.26 ; the nasdaq composite index of 3/31/2014 is 175.11 ; the nasdaq composite index of 3/31/2015 is 204.38 ;
Program: subtract(136.26, 100), divide(#0, 100)
Answer:
str_answer: 36.3%
exe_answer: 0.3626
{"pre_text": ["abiomed , inc .", "and subsidiaries notes to consolidated financial statements 2014 ( continued ) note 3 .", "acquisitions ( continued ) including the revenues of third-party licensees , or ( ii ) the company 2019s sale of ( a ) ecp , ( b ) all or substantially all of ecp 2019s assets , or ( c ) certain of ecp 2019s patent rights , the company will pay to syscore the lesser of ( x ) one-half of the profits earned from such sale described in the foregoing item ( ii ) , after accounting for the costs of acquiring and operating ecp , or ( y ) $ 15.0 million ( less any previous milestone payment ) .", "ecp 2019s acquisition of ais gmbh aachen innovative solutions in connection with the company 2019s acquisition of ecp , ecp acquired all of the share capital of ais gmbh aachen innovative solutions ( 201cais 201d ) , a limited liability company incorporated in germany , pursuant to a share purchase agreement dated as of june 30 , 2014 , by and among ecp and ais 2019s four individual shareholders .", "ais , based in aachen , germany , holds certain intellectual property useful to ecp 2019s business , and , prior to being acquired by ecp , had licensed such intellectual property to ecp .", "the purchase price for the acquisition of ais 2019s share capital was approximately $ 2.8 million in cash , which was provided by the company , and the acquisition closed immediately prior to abiomed europe 2019s acquisition of ecp .", "the share purchase agreement contains representations , warranties and closing conditions customary for transactions of its size and nature .", "purchase price allocation the acquisition of ecp and ais was accounted for as a business combination .", "the purchase price for the acquisition has been allocated to the assets acquired and liabilities assumed based on their estimated fair values .", "the acquisition-date fair value of the consideration transferred is as follows : acquisition date fair value ( in thousands ) ."], "post_text": ["."], "table": [["", "total acquisition date fair value ( in thousands )"], ["cash consideration", "$ 15750"], ["contingent consideration", "6000"], ["total consideration transferred", "$ 21750"]], "table_ori": [["", "Total Acquisition Date Fair Value (in thousands)"], ["Cash consideration", "$15,750"], ["Contingent consideration", "6,000"], ["Total consideration transferred", "$21,750"]]}

Question: what portion of total consideration transferred for acquisition of ecp and ais is cash consideration?
Evidence:
table_1: the cash consideration of total acquisition date fair value ( in thousands ) is $ 15750 ;
table_3: the total consideration transferred of total acquisition date fair value ( in thousands ) is $ 21750 ;
Program: divide(15750, 21750)
Answer:
str_answer: 72.4%
exe_answer: 0.72414
{"pre_text": ["performance graph comparison of five-year cumulative total return the following graph and table compare the cumulative total return on citi 2019s common stock , which is listed on the nyse under the ticker symbol 201cc 201d and held by 65691 common stockholders of record as of january 31 , 2018 , with the cumulative total return of the s&p 500 index and the s&p financial index over the five-year period through december 31 , 2017 .", "the graph and table assume that $ 100 was invested on december 31 , 2012 in citi 2019s common stock , the s&p 500 index and the s&p financial index , and that all dividends were reinvested .", "comparison of five-year cumulative total return for the years ended date citi s&p 500 financials ."], "post_text": ["."], "table": [["date", "citi", "s&p 500", "s&p financials"], ["31-dec-2012", "100.0", "100.0", "100.0"], ["31-dec-2013", "131.8", "132.4", "135.6"], ["31-dec-2014", "137.0", "150.5", "156.2"], ["31-dec-2015", "131.4", "152.6", "153.9"], ["31-dec-2016", "152.3", "170.8", "188.9"], ["31-dec-2017", "193.5", "208.1", "230.9"]], "table_ori": [["DATE", "CITI", "S&P 500", "S&P FINANCIALS"], ["31-Dec-2012", "100.0", "100.0", "100.0"], ["31-Dec-2013", "131.8", "132.4", "135.6"], ["31-Dec-2014", "137.0", "150.5", "156.2"], ["31-Dec-2015", "131.4", "152.6", "153.9"], ["31-Dec-2016", "152.3", "170.8", "188.9"], ["31-Dec-2017", "193.5", "208.1", "230.9"]]}

Question: what was the percentage cumulative total return for the five year period ended 31-dec-2017 of citi common stock?
Evidence:
table_1: date the 31-dec-2012 of citi is 100.0 ; the 31-dec-2012 of s&p 500 is 100.0 ; the 31-dec-2012 of s&p financials is 100.0 ;
table_6: date the 31-dec-2017 of citi is 193.5 ; the 31-dec-2017 of s&p 500 is 208.1 ; the 31-dec-2017 of s&p financials is 230.9 ;
Program: subtract(193.5, const_100), divide(#0, const_100)
Answer:
str_answer: 93.5%
exe_answer: 0.935
{"pre_text": ["performance graph comparison of five-year cumulative total return the following graph and table compare the cumulative total return on citi 2019s common stock , which is listed on the nyse under the ticker symbol 201cc 201d and held by 65691 common stockholders of record as of january 31 , 2018 , with the cumulative total return of the s&p 500 index and the s&p financial index over the five-year period through december 31 , 2017 .", "the graph and table assume that $ 100 was invested on december 31 , 2012 in citi 2019s common stock , the s&p 500 index and the s&p financial index , and that all dividends were reinvested .", "comparison of five-year cumulative total return for the years ended date citi s&p 500 financials ."], "post_text": ["."], "table": [["date", "citi", "s&p 500", "s&p financials"], ["31-dec-2012", "100.0", "100.0", "100.0"], ["31-dec-2013", "131.8", "132.4", "135.6"], ["31-dec-2014", "137.0", "150.5", "156.2"], ["31-dec-2015", "131.4", "152.6", "153.9"], ["31-dec-2016", "152.3", "170.8", "188.9"], ["31-dec-2017", "193.5", "208.1", "230.9"]], "table_ori": [["DATE", "CITI", "S&P 500", "S&P FINANCIALS"], ["31-Dec-2012", "100.0", "100.0", "100.0"], ["31-Dec-2013", "131.8", "132.4", "135.6"], ["31-Dec-2014", "137.0", "150.5", "156.2"], ["31-Dec-2015", "131.4", "152.6", "153.9"], ["31-Dec-2016", "152.3", "170.8", "188.9"], ["31-Dec-2017", "193.5", "208.1", "230.9"]]}

Question: what was the percentage growth of the five-year cumulative total return of s&p financials from 2015 to 2016
Evidence:
table_5: date the 31-dec-2016 of citi is 152.3 ; the 31-dec-2016 of s&p 500 is 170.8 ; the 31-dec-2016 of s&p financials is 188.9 ;
table_6: date the 31-dec-2017 of citi is 193.5 ; the 31-dec-2017 of s&p 500 is 208.1 ; the 31-dec-2017 of s&p financials is 230.9 ;
table_4: date the 31-dec-2015 of citi is 131.4 ; the 31-dec-2015 of s&p 500 is 152.6 ; the 31-dec-2015 of s&p financials is 153.9 ;
Program: subtract(188.9, 153.9), divide(#0, 153.9)
Answer:
exe_answer: 0.22742
{"pre_text": ["performance graph comparison of five-year cumulative total return the following graph and table compare the cumulative total return on citi 2019s common stock , which is listed on the nyse under the ticker symbol 201cc 201d and held by 65691 common stockholders of record as of january 31 , 2018 , with the cumulative total return of the s&p 500 index and the s&p financial index over the five-year period through december 31 , 2017 .", "the graph and table assume that $ 100 was invested on december 31 , 2012 in citi 2019s common stock , the s&p 500 index and the s&p financial index , and that all dividends were reinvested .", "comparison of five-year cumulative total return for the years ended date citi s&p 500 financials ."], "post_text": ["."], "table": [["date", "citi", "s&p 500", "s&p financials"], ["31-dec-2012", "100.0", "100.0", "100.0"], ["31-dec-2013", "131.8", "132.4", "135.6"], ["31-dec-2014", "137.0", "150.5", "156.2"], ["31-dec-2015", "131.4", "152.6", "153.9"], ["31-dec-2016", "152.3", "170.8", "188.9"], ["31-dec-2017", "193.5", "208.1", "230.9"]], "table_ori": [["DATE", "CITI", "S&P 500", "S&P FINANCIALS"], ["31-Dec-2012", "100.0", "100.0", "100.0"], ["31-Dec-2013", "131.8", "132.4", "135.6"], ["31-Dec-2014", "137.0", "150.5", "156.2"], ["31-Dec-2015", "131.4", "152.6", "153.9"], ["31-Dec-2016", "152.3", "170.8", "188.9"], ["31-Dec-2017", "193.5", "208.1", "230.9"]]}

Question: what was the difference in percentage cumulative total return for the five year period ended 31-dec-2017 of citi common stock and s&p financials?
Evidence:
table_1: date the 31-dec-2012 of citi is 100.0 ; the 31-dec-2012 of s&p 500 is 100.0 ; the 31-dec-2012 of s&p financials is 100.0 ;
table_6: date the 31-dec-2017 of citi is 193.5 ; the 31-dec-2017 of s&p 500 is 208.1 ; the 31-dec-2017 of s&p financials is 230.9 ;
Program: subtract(193.5, const_100), divide(#0, const_100), subtract(230.9, const_100), divide(#2, const_100), subtract(#1, #3)
Answer:
exe_answer: -0.374
{"pre_text": ["performance graph comparison of five-year cumulative total return the following graph and table compare the cumulative total return on citi 2019s common stock , which is listed on the nyse under the ticker symbol 201cc 201d and held by 65691 common stockholders of record as of january 31 , 2018 , with the cumulative total return of the s&p 500 index and the s&p financial index over the five-year period through december 31 , 2017 .", "the graph and table assume that $ 100 was invested on december 31 , 2012 in citi 2019s common stock , the s&p 500 index and the s&p financial index , and that all dividends were reinvested .", "comparison of five-year cumulative total return for the years ended date citi s&p 500 financials ."], "post_text": ["."], "table": [["date", "citi", "s&p 500", "s&p financials"], ["31-dec-2012", "100.0", "100.0", "100.0"], ["31-dec-2013", "131.8", "132.4", "135.6"], ["31-dec-2014", "137.0", "150.5", "156.2"], ["31-dec-2015", "131.4", "152.6", "153.9"], ["31-dec-2016", "152.3", "170.8", "188.9"], ["31-dec-2017", "193.5", "208.1", "230.9"]], "table_ori": [["DATE", "CITI", "S&P 500", "S&P FINANCIALS"], ["31-Dec-2012", "100.0", "100.0", "100.0"], ["31-Dec-2013", "131.8", "132.4", "135.6"], ["31-Dec-2014", "137.0", "150.5", "156.2"], ["31-Dec-2015", "131.4", "152.6", "153.9"], ["31-Dec-2016", "152.3", "170.8", "188.9"], ["31-Dec-2017", "193.5", "208.1", "230.9"]]}

Question: as of 2017 what was the ratio of the overall five-year cumulative total return for s&p 500 compared to citi
Evidence:
table_6: date the 31-dec-2017 of citi is 193.5 ; the 31-dec-2017 of s&p 500 is 208.1 ; the 31-dec-2017 of s&p financials is 230.9 ;
Program: subtract(193.5, const_100), subtract(208.1, const_100), divide(#1, #0)
Answer:
str_answer: 1.16
exe_answer: 1.15615
{"pre_text": ["stock performance graph * $ 100 invested on december 31 , 2011 in our stock or in the relevant index , including reinvestment of dividends .", "fiscal year ended december 31 , 2016 .", "( 1 ) delphi automotive plc ( 2 ) s&p 500 2013 standard & poor 2019s 500 total return index ( 3 ) automotive supplier peer group 2013 russell 3000 auto parts index , including american axle & manufacturing , borgwarner inc. , cooper tire & rubber company , dana inc. , delphi automotive plc , dorman products inc. , federal-mogul corp. , ford motor co. , general motors co. , gentex corp. , gentherm inc. , genuine parts co. , goodyear tire & rubber co. , johnson controls international plc , lear corp. , lkq corp. , meritor inc. , standard motor products inc. , stoneridge inc. , superior industries international , tenneco inc. , tesla motors inc. , tower international inc. , visteon corp. , and wabco holdings inc .", "company index december 31 , december 31 , december 31 , december 31 , december 31 , december 31 ."], "post_text": ["dividends the company has declared and paid cash dividends of $ 0.25 and $ 0.29 per ordinary share in each quarter of 2015 and 2016 , respectively .", "in addition , in january 2017 , the board of directors declared a regular quarterly cash dividend of $ 0.29 per ordinary share , payable on february 15 , 2017 to shareholders of record at the close of business on february 6 , 2017. ."], "table": [["company index", "december 31 2011", "december 31 2012", "december 31 2013", "december 31 2014", "december 31 2015", "december 31 2016"], ["delphi automotive plc ( 1 )", "$ 100.00", "$ 177.58", "$ 283.02", "$ 347.40", "$ 414.58", "$ 331.43"], ["s&p 500 ( 2 )", "100.00", "116.00", "153.58", "174.60", "177.01", "198.18"], ["automotive supplier peer group ( 3 )", "100.00", "127.04", "188.67", "203.06", "198.34", "202.30"]], "table_ori": [["Company Index", "December 31, 2011", "December 31, 2012", "December 31, 2013", "December 31, 2014", "December 31, 2015", "December 31, 2016"], ["Delphi Automotive PLC (1)", "$100.00", "$177.58", "$283.02", "$347.40", "$414.58", "$331.43"], ["S&P 500 (2)", "100.00", "116.00", "153.58", "174.60", "177.01", "198.18"], ["Automotive Supplier Peer Group (3)", "100.00", "127.04", "188.67", "203.06", "198.34", "202.30"]]}

Question: what was the percentage increase in cash dividend from 2015 to 2016?
Evidence:
text_4: dividends the company has declared and paid cash dividends of $ 0.25 and $ 0.29 per ordinary share in each quarter of 2015 and 2016 , respectively .
Program: subtract(0.29, 0.25), divide(#0, 0.25)
Answer:
str_answer: 16%
exe_answer: 0.16